The authors thank the following for help and support: Paul Bernstein, MD, PhD, Albert T. Vitale, MD, Christopher Ricks, MD, and Susie Choi, PhD, from the John A. Moran Eye Center, Department of Ophthalmology & Visual Sciences, University of Utah, Salt Lake City; Mike Feilmeier, MD, and Jessica Feilmeier, MD, from the University of Nebraska Medical Center, Omaha; Lisa Nichols, Norma Miller, BS, and Stacie Matthews from the Sharon Eccles Steele Center for Translational Medicine, John A. Moran Eye Center, Department of Ophthalmology & Visual Sciences, University of Utah, Salt Lake City; Lisa S. Hancox, BS, from the Department of Microbiology and Immunology, University of Iowa, Iowa City; Benjamin Abaidoo, MD, from the University of Ghana Medical School, Accra; Sheri McCormick, Laura Cushley, Coilin Ferrin, Courtney Hageman, Albert Asiedu, Ezekiel Brikrong, Paul Lartey, Karima Zouache, PhD, and Joyce Bamford-Addo (Former Speaker of the Parliament of Ghana from 2009 to 2013).
This work was supported in part by the National Eye Institute of the National Institutes of Health under award numbers R01EY024969 (J.C.) and R24EY017404 (G.S.H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support from an Unrestricted Grant from Research to Prevent Blindness, New York, NY, to the Department of Ophthalmology & Visual Sciences, University of Utah.
Disclosure: M.A. Zouache, None; G. Silvestri, None; W.M. Amoaku, None; V. Silvestri, None; W.C. Hubbard, None; C. Pappas, None; S. Akafo, None; S. Lartey, None; R.R. Mastey, None; J. Carroll, None; G.S. Hageman, Voyant Biotherapeutics, LLC (C, I)